Both in Pharmaceuticals
Matinas BioPharma Holdings vs PMGC Holdings
Over the past year MTNB returned −91.2% and ELAB returned −99.8%; their daily moves had a correlation of -0.05.
MTNB −91.2% ELAB −99.8%Growth of $1, one year, split-adjusted
| Metric | MTNB | ELAB |
|---|---|---|
| Price | $1.91 | $2.57 |
| Market cap | $1.9M | $2.1M |
| Today | +4.37% | −0.39% |
| 1 month | −33.7% | −30.0% |
| 6 months | −79.2% | −89.8% |
| Year to date | −78.3% | −99.3% |
| 1 year | −91.7% | −99.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 29.5% |
| Net margin | — | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.8× |
| Net cash | $755.0K | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 773.8% | 676.5% |
| Short % of float | 0.5% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).